Search research articles
Contact Us
Filters
Showing results (361-370 of 438) with videos related to
Page
of 44
Sort By:
Journal of Alzheimer'S Disease : JAD
|
August 29, 2018
Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults
Christa Dang, Karra D Harrington, Yen Ying Lim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 20, 2023
Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults
Michael G Slee, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
JAMA Neurology
|
January 6, 2025
An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial
Niraj M Shanbhag, Jaya L Padmanabhan, Zheng Zhang, et al.
Journal of Alzheimer'S Disease : JAD
|
August 23, 2021
An Online, Person-Centered, Risk Factor Management Program to Prevent Cognitive Decline: Protocol for A Prospective Behavior-Modification Blinded Endpoint Randomized Controlled Trial
Yen Ying Lim, Darshini Ayton, Stephanie Perin, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
|
October 2, 2018
Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults
Christa Dang, Karra D Harrington, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD
|
February 25, 2017
APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults
Simone Hollands, Yen Ying Lim, Simon M Laws, et al.
The International Journal of Neuropsychopharmacology
|
August 31, 2012
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction
Pradeep J Nathan, Jeannette Watson, Jesper Lund, et al.
International Journal of Molecular Sciences
|
July 27, 2022
Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's Disease
Yihan Li, Xin Huang, Christopher Fowler, et al.
Scientific Reports
|
December 11, 2021
Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNI
Rosita Shishegar, Timothy Cox, David Rolls, et al.
Neurology
|
August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up
Samantha C Burnham, Christopher C Rowe, David Baker, et al.
Page
of 44
Search research articles
Search
Showing results (361-370 of 438) with videos related to
Sort By:
Page
of 44
Journal of Alzheimer'S Disease : JAD
|
August 29, 2018
Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults
Christa Dang, Karra D Harrington, Yen Ying Lim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 20, 2023
Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults
Michael G Slee, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
JAMA Neurology
|
January 6, 2025
An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial
Niraj M Shanbhag, Jaya L Padmanabhan, Zheng Zhang, et al.
Journal of Alzheimer'S Disease : JAD
|
August 23, 2021
An Online, Person-Centered, Risk Factor Management Program to Prevent Cognitive Decline: Protocol for A Prospective Behavior-Modification Blinded Endpoint Randomized Controlled Trial
Yen Ying Lim, Darshini Ayton, Stephanie Perin, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
|
October 2, 2018
Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults
Christa Dang, Karra D Harrington, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD
|
February 25, 2017
APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults
Simone Hollands, Yen Ying Lim, Simon M Laws, et al.
The International Journal of Neuropsychopharmacology
|
August 31, 2012
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction
Pradeep J Nathan, Jeannette Watson, Jesper Lund, et al.
International Journal of Molecular Sciences
|
July 27, 2022
Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's Disease
Yihan Li, Xin Huang, Christopher Fowler, et al.
Scientific Reports
|
December 11, 2021
Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNI
Rosita Shishegar, Timothy Cox, David Rolls, et al.
Neurology
|
August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up
Samantha C Burnham, Christopher C Rowe, David Baker, et al.
Page
of 44